Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro

Mao,Haiting; Gu,Hongtao; Qu,Xun; Sun,Jintang; Song,Bingfeng; Gao,Wenjuan; Liu,Jia; Shao,Qianqian

doi:10.3892/ijmm.2012.1176

Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro

Authors:
- Haiting Mao
- Hongtao Gu
- Xun Qu
- Jintang Sun
- Bingfeng Song
- Wenjuan Gao
- Jia Liu
- Qianqian Shao
View Affiliations

Affiliations: Institute of Basic Medical Sciences, Qilu Hospital, Shandong University, Jinan, Shandong, P.R. China
Published online on: November 8, 2012 https://doi.org/10.3892/ijmm.2012.1176
Pages: 213-218

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dihydroartemisinin (DHA), a semi-synthetic derivative and active metabolite of artemisinin, has been shown to have profound anticancer potential in addition to its strong anti-malarial activity. The purpose of the present study was to thoroughly investigate the anti-neoplastic effects induced by DHA and to provide a molecular basis for the use of DHA in the treatment of breast cancer. Our results demonstrated that DHA could significantly inhibit the cell proliferation of breast cancer in a dose- and time-dependent manner that was associated with induced apoptosis and G0/G1 cell cycle arrest, and the half maximal inhibitory concentrations (IC50) of DHA treatment were 60.03, 33.86 and 17.18 µM for 24, 48 and 72 h, respectively. Moreover, the DHA treatment dramatically increased the protein expression of caspase-8, cleaved caspase-9, activated Bid and induced the release of cytochrome c from mitochondria into the cytosol. In addition, the apoptotic action of DHA was associated with the increased expression of the pro-apoptotic gene Bim and a decreased expression of the anti-apoptotic gene Bcl-2. Therefore, the mitochondrial pathway is involved in the apoptosis of breast cancer cells induced by DHA and the imbalance of the Bim/Bcl-2 interaction may promote the beneficial effect against breast cancer cells. Overall, our study provides the scientific rationale for the clinical usage of DHA for breast cancer.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Antoon JW, Lai R, Struckhoff AP, et al: Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance. Sci Rep. 2:5392012. View Article : Google Scholar : PubMed/NCBI
3	White NJ: Qinghaosu (artemisinin): the price of success. Science. 320:330–334. 2008. View Article : Google Scholar : PubMed/NCBI
4	German PI and Aweeka FT: Clinical pharmacology of artemisinin-based combination therapies. Clin Pharmacokinet. 47:91–102. 2008. View Article : Google Scholar : PubMed/NCBI
5	Efferth T: Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin - from bench to bedside. Planta Med. 73:299–309. 2007. View Article : Google Scholar : PubMed/NCBI
6	Efferth T, Dunstan H, Sauerbrey A, Miyachi H and Chitambar CR: The anti-malarial artesunate is also active against cancer. Int J Oncol. 18:767–773. 2001.PubMed/NCBI
7	Klayman DL: Qinghaosu (artemisinin): an antimalarial drug from China. Science. 228:1049–1055. 1985. View Article : Google Scholar : PubMed/NCBI
8	Disbrow GL, Baege AC, Kierpiec KA, et al: Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res. 65:10854–10861. 2005. View Article : Google Scholar : PubMed/NCBI
9	Hosoya K, Murahari S, Laio A, London CA, Couto CG and Kisseberth WC: Biological activity of dihydroartemisinin in canine osteosarcoma cell lines. Am J Vet Res. 69:519–526. 2008. View Article : Google Scholar : PubMed/NCBI
10	Mercer AE, Copple IM, Maggs JL, O’Neill PM and Park BK: The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials. J Biol Chem. 286:987–996. 2011. View Article : Google Scholar : PubMed/NCBI
11	Zhang S and Gerhard GS: Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target. PLoS One. 4:e74722009. View Article : Google Scholar : PubMed/NCBI
12	Toovey S, Bustamante LY, Uhlemann AC, East JM and Krishna S: Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity. Basic Clin Pharmacol Toxicol. 103:209–213. 2008. View Article : Google Scholar
13	Handrick R, Ontikatze T, Bauer KD, et al: Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway. Mol Cancer Ther. 9:2497–2510. 2010. View Article : Google Scholar : PubMed/NCBI
14	Eckstein-Ludwig U, Webb RJ, Van Goethem ID, et al: Artemisinins target the SERCA of Plasmodium falciparum. Nature. 424:957–961. 2003. View Article : Google Scholar : PubMed/NCBI
15	Chen T, Li M, Zhang R and Wang H: Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy. J Cell Mol Med. 13:1358–1370. 2009. View Article : Google Scholar : PubMed/NCBI
16	Wang SJ, Gao Y, Chen H, et al: Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett. 293:99–108. 2010. View Article : Google Scholar : PubMed/NCBI
17	Chen M, Chen TS, Lu YY, Liu CY and Qu JL: Dihydroarteminsinin-induced apoptosis is not dependent on the translocation of Bim to the endoplasmic reticulum in human lung adenocarcinoma cells. Pathol Oncol Res. 18:809–816. 2012. View Article : Google Scholar : PubMed/NCBI
18	He Q, Shi J, Shen XL, et al: Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells. Cancer Biol Ther. 9:819–824. 2010. View Article : Google Scholar : PubMed/NCBI
19	Singh NP and Lai H: Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci. 70:49–56. 2001. View Article : Google Scholar : PubMed/NCBI
20	Singh NP and Lai HC: Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res. 25:4325–4331. 2005.PubMed/NCBI
21	Zhang CZ, Zhang H, Yun J, Chen GG and Lai PB: Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol. 83:1278–1289. 2012. View Article : Google Scholar : PubMed/NCBI
22	Huang XJ, Ma ZQ, Zhang WP, Lu YB and Wei EQ: Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells. J Pharm Pharmacol. 59:849–856. 2007. View Article : Google Scholar : PubMed/NCBI
23	Mercer AE, Maggs JL, Sun XM, et al: Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. J Biol Chem. 282:9372–9382. 2007. View Article : Google Scholar : PubMed/NCBI
24	Gao N, Budhraja A, Cheng S, et al: Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo. Apoptosis. 16:511–523. 2011. View Article : Google Scholar : PubMed/NCBI
25	Reungpatthanaphong P and Mankhetkorn S: Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines. Biol Pharm Bull. 25:1555–1561. 2002. View Article : Google Scholar : PubMed/NCBI
26	Yuan J, Murrell GA, Trickett A and Wang MX: Involvement of cytochrome c release and caspase-3 activation in the oxidative stress-induced apoptosis in human tendon fibroblasts. Biochim Biophys Acta. 1641:35–41. 2003. View Article : Google Scholar : PubMed/NCBI
27	Noori S and Hassan ZM: Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo. Cell Immunol. 271:67–72. 2011. View Article : Google Scholar : PubMed/NCBI
28	Aung W, Sogawa C, Furukawa T and Saga T: Anticancer effect of dihydroartemisinin (DHA) in a pancreatic tumor model evaluated by conventional methods and optical imaging. Anticancer Res. 31:1549–1558. 2011.PubMed/NCBI
29	Kelman Z: PCNA: structure, functions and interactions. Oncogene. 14:629–640. 1997. View Article : Google Scholar : PubMed/NCBI
30	Lu JJ, Chen SM, Ding J and Meng LH: Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line. Mol Cell Biochem. 360:329–337. 2012. View Article : Google Scholar : PubMed/NCBI
31	Morrissey C, Gallis B, Solazzi JW, et al: Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells. Anticancer Drugs. 21:423–432. 2010. View Article : Google Scholar : PubMed/NCBI
32	Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K and Los M: Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood. 98:1542–1548. 2001. View Article : Google Scholar : PubMed/NCBI
33	Youle RJ and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 9:47–59. 2008. View Article : Google Scholar : PubMed/NCBI
34	Bouillet P, Purton JF, Godfrey DI, et al: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:922–926. 2002. View Article : Google Scholar : PubMed/NCBI
35	Zhao L, He F, Liu H, et al: Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule. J Biol Chem. 287:1054–1065. 2012. View Article : Google Scholar : PubMed/NCBI
36	Wojciechowski S, Tripathi P, Bourdeau T, et al: Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med. 204:1665–1675. 2007.PubMed/NCBI
37	Willis SN, Fletcher JI, Kaufmann T, et al: Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 315:856–859. 2007. View Article : Google Scholar : PubMed/NCBI